Aim To investigate the relations between hormonal status of the thyroid gland and mineral bone density in women in menopause with or without osteoporosis. Methods The study included 120 postmenopausal women, who were divided into two groups. Group I included postmenopausal patients with osteoporosis, of whom 30 were in the early stages of postmenopause, and 30 of them where in the late postmenopausal phase. The second group included patients with preserved bone mass, of which 30 were in the early stage of postmenopause, and 30 were in the late postmenopausal phase. Bone densitometry (DEXA) was performed for all patients, along with analysis of the level of follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3). Results A statistically significant correlation between TSH level and mineral bone density in the lumbar spine level (r=0.27) was found in early postmenopausal women (r <0.05), TSH and T-score at the level of the lumbar spine (r=0.31) (p<0.05), as well as between TSH and mineral content of the femur bone (r=0.29; <0.05). There was statistically significant independent association between thyroxine and mineral bone density at the lumbar spine level in the late postmenopausal women (ß=0.29; p=0.025). Conclusion In the early postmenopausal phase, TSH was associated with mineral bone density in the lumbar spine and in the area of the femur.
Clarke B, Khosla S. Physiology of bone loss. Radiol Clin North Am. 2010. p. 483–95.
2.
Lunenfeld B, Stratton P. The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol. 2013. p. 643–59.
3.
Dalal P, Agarwal M. Postmenopausal syndrome.
4.
Indian J Psychiatry. 2015. p. 222–32.
5.
Carpintero P, Caeiro J, Carpintero R, Morales A, Silva S, Mesa M. Complications of hip fractures: A review. World J Orthop. 2014. p. 402–11.
6.
Murphy E, Glüer C, Reid D, Felsenberg D, Roux C, Eastell R, et al. Thyroid function within the upper normal range is associated with reduced bone mineral density and increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab. 2010. p. 3173–81.
7.
Kim D, Khang Y, Koh J, Shong Y, Kim G. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin Endocrinol (Oxf). 2006. p. 86–90.
8.
Pater A, Nowacki W, Sypniewska G. Thyroid-stimulating hormone within normal range does not affect bone turnover in euthyroid postmenopausal women with osteoporotic fracture -a preliminary report. EJIFCC. 2011. p. 113–7.
9.
Marwaha R, Garg M, Tandon N, Kanwar R, Narang A, Sastry A, et al. Thyroid function and bone mineral density among Indian subjects. Indian J Endocrinol Metab. 2012. p. 575–9.
10.
Bauer D, Ettinger B, Nevitt M, Stone K. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001. p. 561–8.
11.
Pirro M, Manfredelli M, Scarponi A, Lupattelli G, Bagaglia F, Melis F, et al. Association between thyroid hormone levels, the number of circulating osteoprogenitor cells, and bone mineral density in euthyroid postmenopausal women. Metabolism. 2012. p. 569–76.
12.
Garnero P, Sornay-Rendu E, Chapuy M, Delmas P. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996. p. 337–49.
13.
Van Der Deure W, Uitterlinden A, Hofman A, Rivadeneira F, Pols H, Peeters R, et al. Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf). 2008. p. 175–81.
14.
Zovkova I, Hill M. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Endocr Regul. 2008. p. 12–7.
15.
Lee W. Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch Med Res. 2006. p. 511–6.
16.
Murphy E, Williams G. T3 rather than TSH mediates the effects of altered thyroid status on bone turnover in man. Endocrine Abstracts. 2007. p. P328.
17.
Abe E, Marians R, Yu W, Wu X, Ando T, Li Y, et al. TSH is a negative regulator of skeletal remodeling. Cell. 2003. p. 151–62.
18.
Pouilles J, Tremollieres F, Ribot C. Effects of menopuseon femoral and vertebral bone loss. J Bone Miner Res. 1995. p. 1531–6.
19.
Sampath K, Šimic P, Sendak R, Draca N, Schiavi S, Mcpherson J, et al. Thyroid stimulating hormone (TSH) may serve as a novel bone anabolic agent for postmenopausal osteoporosis. Calcif Tissue Int. 2006.
20.
Tuchendler D, Bolanowski M. The influence of thyroid dysfunction on bone metabolism. Thyroid Res. 2014. p. 12.
21.
Williams G, Bassett J. Thyroid diseases and bone health. J Endocrinol Invest. 2018. p. 99–109.
22.
Bassett J, Williams G. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016. p. 135–87.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
